Relay Therapeutics Inc (RLAY)

11:02 AM

Relay Therapeutics, Inc. (RLAY) Discusses Mutant Selective PI3K-alpha Inhibitor for PIK3CA-Driven Vascular AnomaliesSlideshow (NASDAQ:RLAY) 2026-04-06 - seekingalpha.com

11:02 AM

05:03 AM

SG Americas Securities LLC Acquires 189,004 Shares of Relay Therapeutics, Inc. $RLAY - MarketBeat

05:03 AM

04:11 AM

Relay Therapeutics (RLAY) Surges 16.4%: Is This an Indication of Further Gains? - qz.com

04:11 AM

02:42 AM

Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

02:42 AM

12:01 PM

Relay Therapeutics (RLAY) climbs 16% ahead of cancer treatment update - MSN

12:01 PM

Apr 05, 2026

Relay Therapeutics, Inc. (RLAY) stock price, news, quote and history - uk.finance.yahoo.com

Apr 05, 2026

Apr 05, 2026

Relay Therapeutics (RLAY) Jumps 16.4%: Does This Signal More Upside Ahead? - Bitget

Apr 05, 2026

Apr 05, 2026

Aug Highlights: Can Relay Therapeutics Inc scale operations efficiently2026 Short Interest & Weekly High Return Stock Opportunities - baoquankhu1.vn

Apr 05, 2026

Apr 04, 2026

Relay Therapeutics (RLAY) Is Up 30.6% After Expanding Zovegalisib Into Vascular Anomalies Data Reveal - Yahoo Finance

Apr 04, 2026

Apr 03, 2026

Which Is a Better Investment, ACADIA Pharmaceuticals Inc. or Relay Therapeutics, Inc. Stock? - AAII.com

Apr 03, 2026

Apr 03, 2026

Relay Therapeutics (NASDAQ:RLAY) Reaches New 52-Week HighTime to Buy? - MarketBeat

Apr 03, 2026

Apr 03, 2026

Relay Therapeutics to Present Initial Clinical Data on Zovegalisib in Vascular Anomalies at the International Society for the Study of Vascular Anomalies World Congress 2026 - Sahm

Apr 03, 2026

Apr 03, 2026

Relay Therapeutics (RLAY) Climbs 16% Ahead of Cancer Treatment Update - insidermonkey.com

Apr 03, 2026

Apr 03, 2026

Relay Therapeutics to Present Initial Clinical Data on Zovegalisib at Vascular Anomalies Conference - nationaltoday.com

Apr 03, 2026

Apr 02, 2026

5 Stocks With Easy 8-20% Gains - Insider Monkey

Apr 02, 2026

Apr 02, 2026

First zovegalisib results in about 20 vascular anomaly patients due in May - Stock Titan

Apr 02, 2026

Apr 02, 2026

Relay Therapeutics stock hits 52-week high at $11.52 By Investing.com - Investing.com Canada

Apr 02, 2026

Apr 02, 2026

Relay Therapeutics (NASDAQ:RLAY) Stock Price Up 6.4%Here's What Happened - MarketBeat

Apr 02, 2026

Apr 02, 2026

Relay Therapeutics stock hits 52-week high at $11.52 - Investing.com

Apr 02, 2026

Mar 31, 2026

Earnings Update: Is Relay Therapeutics Inc likely to announce a buybackEarnings Overview Summary & Free Safe Capital Growth Stock Tips - baoquankhu1.vn

Mar 31, 2026

Mar 30, 2026

Will Relay Therapeutics Inc benefit from government policyQuarterly Profit Report & Community Consensus Picks - baoquankhu1.vn

Mar 30, 2026

Mar 30, 2026

Assessing Relay Therapeutics (RLAY) Valuation After New ReDiscover Trial Data And FDA Breakthrough Status - simplywall.st

Mar 30, 2026

Mar 30, 2026

RLAY SEC FilingsRelay Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 30, 2026

Mar 28, 2026

Relay Therapeutics (RLAY) price target increased by 17.50% to 17.43 - MSN

Mar 28, 2026

Mar 27, 2026

Vanguard realignment reports 0 Relay Therapeutics shares (RLAY) - Stock Titan

Mar 27, 2026

Mar 27, 2026

Aug Levels: Will Relay Therapeutics Inc benefit from green energy policies2026 Technical Overview & Smart Swing Trading Alerts - baoquankhu1.vn

Mar 27, 2026

Mar 26, 2026

Is Relay Therapeutics a Buy in 2026? One Institutional Investor Just Made a $6 Million Bet. - AOL.com

Mar 26, 2026

Mar 25, 2026

PERCEPTIVE ADVISORS LLC Acquires Significant Stake in Relay Ther - GuruFocus

Mar 25, 2026

Mar 25, 2026

Relay Therapeutics unveils educational resource on mutant selective PI3Kα inhibitor for vascular anomalies - Traders Union

Mar 25, 2026

Mar 25, 2026

Aug Summary: Will Relay Therapeutics Inc benefit from government policy2026 Macro Impact & Fast Moving Trade Plans - baoquankhu1.vn

Mar 25, 2026

Mar 25, 2026

HC Wainwright Has Positive Outlook for RLAY Q1 Earnings - MarketBeat

Mar 25, 2026

Mar 23, 2026

RLAY: HC Wainwright & Co. Raises Price Target to $19.00, Maintai - GuruFocus

Mar 23, 2026

Mar 23, 2026

H.C. Wainwright raises Relay Therapeutics price target on trial data By Investing.com - Investing.com Australia

Mar 23, 2026

Mar 23, 2026

Relay Therapeutics (NASDAQ:RLAY) Stock Price Expected to Rise, HC Wainwright Analyst Says - MarketBeat

Mar 23, 2026

Mar 23, 2026

H.C. Wainwright raises Relay Therapeutics price target on trial data - Investing.com

Mar 23, 2026

Mar 23, 2026

H.C. Wainwright Maintains Relay Therapeutics(RLAY.US) With Buy Rating, Raises Target Price to $19 - Moomoo

Mar 23, 2026

Mar 23, 2026

Aug Update: What is the earnings history of Relay Therapeutics IncTrade Analysis Report & Target Return Focused Picks - baoquankhu1.vn

Mar 23, 2026

Mar 20, 2026

Relay Therapeutics Inc receives Investment Bank Analyst Rating Update By Investing.com - Investing.com Canada

Mar 20, 2026

Mar 20, 2026

Raymond James reiterates Strong Buy on Relay Therapeutics stock By Investing.com - Investing.com Canada

Mar 20, 2026

Mar 20, 2026

Profit Review: Can Relay Therapeutics Inc sustain its profitability2026 Catalysts & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn

Mar 20, 2026

Mar 20, 2026

Relay Therapeutics Price Target Raised to $17.00 - National Today

Mar 20, 2026

Mar 19, 2026

Relay Therapeutics (RLAY) — Perceptive entities report 5.3% stake - Stock Titan

Mar 19, 2026

Mar 19, 2026

Nextech Invest Increases Relay Therapeutics Stake in Q4 2025 | Portfolio UpdateNews and Statistics - IndexBox

Mar 19, 2026

Mar 19, 2026

Is Relay Therapeutics a Buy in 2026? One Institutional Investor Just Made a $6 Million Bet. - The Motley Fool

Mar 19, 2026

Mar 18, 2026

Relay Therapeutics (RLAY) Receives a Buy from Wells Fargo - The Globe and Mail

Mar 18, 2026